Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)

Study ID
NCT01230697

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

SORHORM

Trial Summary

The study includes the recruitment of patients with advanced renal cells carcinoma and hepatocarcinoma in treatment with sorafenib. Multicenter cohort study. It is a prospective observational study.

More informations

Trial Starting Date

Jun 30,2010

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit